January 10, 2024
Emyria (ASX:EMD) offers new hope to Australia’s PTSD non-responders
Emyria authorised to prescribe MDMA to treat Australian’s with PTSD.
Tag: BioTech
November 15, 2023
Argenica (ASX:AGN) granted Orphan Drug Designation by the FDA
An Orphan Designation opens up tax credits for clinical trials, user fee exemptions, and potentially seven years of market exclusivity.